Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NeuroTheryX

NeuroTheryX?uq=AFYHfsyn
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Owner and operator of a drug discovery company intended to treat multiple sclerosis and other diseases of the central nervous system. The company's discovery platform is developing novel orally available small molecule therapeutics for the treatment of nervous system diseases and defines highly predictive and efficient biology-driven models with a focused and prioritized chemistry approach, enabling healthcare providers to restore their patients by treating neurodegenerative diseases.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare
Primary Office
  • San Diego, CA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NeuroTheryX’s full profile, request a free trial.

NeuroTheryX Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 28-Aug-2017 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NeuroTheryX Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0

NeuroTheryX Executive Team (1)

Name Title Board
Seat
Contact
Info
Sam Scanga Ph.D Director of Research